The virus with royal protection

Methylation marks on the mRNA of a herpesvirus recruit members of the so-called Royal protein family that allow the virus to replicate.

Image credit: Public domain

When a cell needs to make a protein, it reads from the master copy of the gene in the DNA and prints out temporary duplicates called mRNA. These duplicates then act as templates for protein production. Both DNA and mRNA can be further modified by adding on chemical tags that recruit specific proteins. While chemical modifications in DNA are known to control the activity of genes, their role in mRNA is only just being uncovered.

One of the most common chemical modifications in mRNA is the addition of a methyl group called m6A. This methyl group has also been found in the mRNA of certain viruses, including the Kaposi’s sarcoma-associated herpesvirus (KSHV) which causes cancer. Recent work has shown that a family of proteins, known as the YTH family, can recognise and bind to this specific methyl group and regulate the rate at which mRNA degrades. To investigate whether other proteins can recognise m6A, Baquero-Pérez et al. mapped the m6A residues of mRNAs encoded by KSHV genes and looked at which proteins the methyl mark interacts with.

The experiments revealed that a family of proteins – nicknamed the ‘Royal family’ – that recognise methyl groups in proteins, can also bind to mRNA that contains m6A. Baquero-Pérez et al. showed that a member of this family, SND1, can read the m6A methyl mark on mRNAs from both the virus and the host cell. Further experiments showed that SND1 binds to and stabilises a viral mRNA which provides the template for a protein that the virus needs to replicate. When SND1 was removed from human immune cells infected with KSHV, this caused the virus to replicate less efficiently.

The discovery that the Royal family of proteins can recognise methylated mRNA as well as methylated proteins suggests that there may be a common feature that allows proteins to read methylation. Understanding the shape of this feature could lead to new treatments that block viruses from making the proteins they need to replicate.